...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Gilead GS-5829 Perspective
4
Jul 20, 2017 12:26PM
3
Jul 21, 2017 02:54PM
3
Jul 22, 2017 04:44PM
4
Jul 23, 2017 08:55AM

Nbb - I have heard there are more than two companies at the table and something about mid to late September.

tada

Share
New Message
Please login to post a reply